HEXALEN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hexalen, and when can generic versions of Hexalen launch?
Hexalen is a drug marketed by Eisai Inc and is included in one NDA.
The generic ingredient in HEXALEN is altretamine. There is one drug master file entry for this compound. Additional details are available on the altretamine profile page.
Summary for HEXALEN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 107 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for HEXALEN |
DailyMed Link: | HEXALEN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for HEXALEN
US Patents and Regulatory Information for HEXALEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eisai Inc | HEXALEN | altretamine | CAPSULE;ORAL | 019926-001 | Dec 26, 1990 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |